Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death globally and liver transplantation (LT) can serve as the best curative treatment option. However, HCC recurrence after LT remains the major obstacle to the long-term survival of recipients. Recently, immune checkpoin...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jingyu Jiang, Haitao Huang, Ruihan Chen, Yimou Lin, Qi Ling
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2023-02-01
Цуврал:	Frontiers in Immunology
Нөхцлүүд:	hepatocellular carcinoma liver transplantation immune checkpoint inhibitor immunosuppression transplant tolerance
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1092401/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!